Source: Pharmacopsychiatry. Conference titles: Symposium of the AGNP. Unidade: FM
Subjects: RATOS, DOENÇA DE ALZHEIMER, FOSFOLIPASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHAEFFER, E. L. e SCHMITT, A. e GATTAZ, W. F. Chronic inhibition of brain phospholipase A2 in rats as a model to investigate Alzheimer-related alterations: a preliminary study. Pharmacopsychiatry. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1055/s-2007-991814. Acesso em: 27 dez. 2024. , 2007APA
Schaeffer, E. L., Schmitt, A., & Gattaz, W. F. (2007). Chronic inhibition of brain phospholipase A2 in rats as a model to investigate Alzheimer-related alterations: a preliminary study. Pharmacopsychiatry. New York: Faculdade de Medicina, Universidade de São Paulo. doi:10.1055/s-2007-991814NLM
Schaeffer EL, Schmitt A, Gattaz WF. Chronic inhibition of brain phospholipase A2 in rats as a model to investigate Alzheimer-related alterations: a preliminary study [Internet]. Pharmacopsychiatry. 2007 ; 40( 5): 234.[citado 2024 dez. 27 ] Available from: https://doi.org/10.1055/s-2007-991814Vancouver
Schaeffer EL, Schmitt A, Gattaz WF. Chronic inhibition of brain phospholipase A2 in rats as a model to investigate Alzheimer-related alterations: a preliminary study [Internet]. Pharmacopsychiatry. 2007 ; 40( 5): 234.[citado 2024 dez. 27 ] Available from: https://doi.org/10.1055/s-2007-991814
